Page last updated: 2024-08-26

n-glycylalanine and Lymphoproliferative Disorders

n-glycylalanine has been researched along with Lymphoproliferative Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barlow, EA; Burgess, RR; Duellman, SJ; Hagemeier, SR; Kenney, SC; Khanna, R; Ma, S; Sun, X; Tellam, J1

Other Studies

1 other study(ies) available for n-glycylalanine and Lymphoproliferative Disorders

ArticleYear
Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism.
    Proceedings of the National Academy of Sciences of the United States of America, 2010, Feb-16, Volume: 107, Issue:7

    Topics: Animals; Apoptosis; Benzoquinones; Cell Line, Tumor; Dipeptides; DNA Primers; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Viral; Herpesvirus 4, Human; HSP90 Heat-Shock Proteins; Humans; Immunoblotting; Immunoprecipitation; Lactams, Macrocyclic; Lymphoproliferative Disorders; Mice; Mice, SCID; Reverse Transcriptase Polymerase Chain Reaction; Virus Replication

2010